A phase I study of a next-generation CAR T cell therapy showed a 52 percent complete remission rate for patients with relapsed/refractory lymphoma. A next-generation "armored" CAR T cell therapy ...

A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas continued to resist multiple rounds of other cancer treatments ...

The WEHI-led study used a novel approach combined with cutting-edge mRNA vaccine technology to increase the formation of a type of T cell which has remarkable self-renewing capacity and can ...

Azahar emulator has released a new candidate build with major feature additions, such as Turbo mode ... meaning it isn’t stable enough to be considered a stable release, but it can become ...

Mumbai, May 8: The wait is finally over for thousands of daily commuters in Mumbai as the Mumbai Metro Aqua Line 3 extension is set to be inaugurated on Friday (May 9) and the line will be open ...

The Turbo gurus at Garrett Motion, once known as AiResearch, have figured out how to harvest the energy in a fuel cell’s hot ...

Bringing much-needed relief to Mumbai’s traffic congestion, the newly inaugurated Mumbai Metro Aqua Line 3 from BKC to Acharya Atre Chowk, Worli is now operational. This stretch includes six ...

Yescarta – a CD19-directed genetically modified autologous T-cell immunotherapy investigated in the ZUMA-1 trial – is the first chimeric antigen receptor (CAR) T-cell therapy recommended for ...

The Rite Aid at North Sixth and Greenwich streets in Reading. Rite Aid is again seeking bankruptcy protection as the struggling drugstore chain says it will try to sell substantially all of its ...

CAMBRIDGE, Mass., May 8, 2025 /PRNewswire/ -- Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches to precision T cell activation, today announced that ...